IPP Bureau

Solara Active Pharma Science clocks net profit of Rs 50.13 crore in Q1FY22
Solara Active Pharma Science clocks net profit of Rs 50.13 crore in Q1FY22

By IPP Bureau - August 04, 2021

Aditya Puri former MD of HDFC bank joins Solara board as chairman

Mindpeers launches on-demand behavioural healthcare platform
Mindpeers launches on-demand behavioural healthcare platform

By IPP Bureau - August 04, 2021

It is designed to tackle mental health issues

Evexia Lifecare to manufacture API of Isometa
Evexia Lifecare to manufacture API of Isometa

By IPP Bureau - August 03, 2021

Robust demand for the product across the Middle East, Africa and Latin America

Nureca Ltd PAT at Rs 36.19 crore in Q1FY22
Nureca Ltd PAT at Rs 36.19 crore in Q1FY22

By IPP Bureau - August 03, 2021

Nureca Ltd has reported financial results for the period ended June 30, 2021.

PLI Scheme to generate export potential of Rs 196,000 crore by 2027 : Mandaviya
PLI Scheme to generate export potential of Rs 196,000 crore by 2027 : Mandaviya

By IPP Bureau - August 03, 2021

The scheme incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales

Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr
Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr

By IPP Bureau - August 03, 2021

The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.

Abbott's Freestyle Libre 2 Ios App Cleared In U.S
Abbott's Freestyle Libre 2 Ios App Cleared In U.S

By IPP Bureau - August 03, 2021

FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app that allows users to check their glucose with a compatible iPhone every minute with optional real-time glucose alarms

NPPA monitors and caps prices of essential drugs: Mandaviya
NPPA monitors and caps prices of essential drugs: Mandaviya

By IPP Bureau - August 03, 2021

NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level

Healthium Medtech acquires SGK Lab’s AbGel gelatin business
Healthium Medtech acquires SGK Lab’s AbGel gelatin business

By IPP Bureau - August 03, 2021

Complementary business models are the reason for the acquisition

Meddo acquires Doxper in a cash and stock deal
Meddo acquires Doxper in a cash and stock deal

By IPP Bureau - August 03, 2021

This deal makes Meddo, one of the largest health-tech players in India

API exports surpass imports by value in 2020-21
API exports surpass imports by value in 2020-21

By IPP Bureau - August 03, 2021

The govt has rolled out three schemes for promoting the manufacture of API

Drug exports grow on the back of govt support
Drug exports grow on the back of govt support

By IPP Bureau - August 03, 2021

Drug formulations and biologics make impressive gains

AYUSH 64 effective in mild and moderate COVID 19
AYUSH 64 effective in mild and moderate COVID 19

By IPP Bureau - August 03, 2021

It works as an adjunct to standard care based on robust clinical trials

Glenmark signs agreement with SaNOtize to manufacture NONS
Glenmark signs agreement with SaNOtize to manufacture NONS

By IPP Bureau - August 02, 2021

The Phase III clinical trial for NONS is expected to be completed by Q4 2021.

Ajanta Pharma aims to file 10-12 ANDAs per annum
Ajanta Pharma aims to file 10-12 ANDAs per annum

By IPP Bureau - August 02, 2021

India business is growing as per projections; whereas US business will bounce back soon.

Latest Stories

Interviews

Packaging